World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 

Abstract

RELATIONSHIP BETWEEN HYPERURICEMIA AND PERINATAL OUTCOMES AMONG PREGNANT HYPERTENSIVE WOMEN

*Dr. Mehasin Kamal Saleh Zuwayd and Dr. Faeza Kamal Salih

ABSTRACT

This study aimed to determine the relationship between hyperuricemia and perinatal outcome in pregnancy induced hypertension. This prospective and observational study was carried out in Al-Falluja Teaching Hospital for Gynecology and Pediatrics – Falluja-Anbar /Iraq. The study included (75) primigravida female patients in the third trimester (after 32 weeks gestation) with pregnancy induced hypertension. Serum uric acid assay was done then the patients were classified into three groups according to uric acid levels; Group I (low hyperuricemia) uric acid below 25th percentile (<3.7 mg/dl ), group II (middle hyperuricemia) uric acid from 25th to 75th percentile (3.8 to 5.7 mg/dl ) and group III (high hyperuricemia) uric acid above 75th percentile (>5.8 mg/dl). The maternal outcome was followed up as (eclampsia, HELLP, acute renal failure and accidental hemorrhage) and fetal out- comes (stillbirth, prematurity, IUGR and IUFD). The results showed statistically significant increase of serum uric acid, urea and creatinine in high group compared to middle and low ones. Bad fetal outcome and pregnancy complications were directly proportional to the serum uric acid levels. It can be concluded for our study that hyperuricemia may be used in the prognosis of adverse perinatal outcomes in pregnancy induced hypertension, and that serum uric acid levels is a useful and inexpensive marker for predicting adverse perinatal outcomes.

[Full Text Article]   [Download Certificate]

WJPLS CITATION

  All Since 2019
 Citation  422  322
 h-index  9  7
 i10-index  4  2

INDEXING

NEWS & UPDATION

    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here